Vicarious Surgical (NYSE:RBOT – Get Free Report) posted its earnings results on Monday. The company reported ($2.43) earnings per share (EPS) for the quarter, beating the consensus estimate of ($2.69) by $0.26, Zacks reports. The firm had revenue of $2.09 million during the quarter. During the same period in the prior year, the company posted ($2.25) EPS.
Vicarious Surgical Stock Performance
NYSE:RBOT opened at $8.20 on Wednesday. The company has a fifty day moving average of $12.56 and a two-hundred day moving average of $10.60. The stock has a market capitalization of $48.42 million, a PE ratio of -0.80 and a beta of 1.35. Vicarious Surgical has a fifty-two week low of $4.27 and a fifty-two week high of $19.00.
Wall Street Analysts Forecast Growth
Separately, Piper Sandler decreased their target price on shares of Vicarious Surgical from $10.50 to $8.50 and set a “neutral” rating for the company in a research note on Tuesday.
Vicarious Surgical Company Profile
Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
Further Reading
- Five stocks we like better than Vicarious Surgical
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- 3 Hot Stock Upgrades as Analysts Look Ahead to Q2 Earnings
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- Stock Dividend Cuts Happen Are You Ready?
- 3 Must-Own Stocks to Build Wealth This Decade
Receive News & Ratings for Vicarious Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vicarious Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
